Interviews

Jaron Stout, PharmD, owner, consulting pharmacist, Collaborative Pharmacy Consultants, discusses how pharmacists can work alongside physicians and other members of a primary care team, and help to relieve 'prescribing cascades.'

Mary Koslap‐Petraco DNP, PNPPC‐BC, CPNP, FAANP of Stony Brook University School of Nursing and Pediatric Nurse Practitioner House Calls advises nurses to listen to concerned parents and assure them they want the best for their children.

Chris Kepinski, PharmD, sat down with Specialty Pharmacy Times at the National Community Oncology Dispensing Association conference in Denver, Colorado to discuss how treatment support kits act a vital resource for patients throughout their treatment.

Eric Dallara, RPh, pharmacist for the New England Cancer Specialists explains the current challenges in the industry, especially regarding payment plans and payment reform during the National Community Oncology Dispensing Association, Inc. in Denver, Colorado.

Ali McBride, PharmD, MS, BCOP, FASHP, FAzPA discusses the emerging influence of NCODA chemotherapy education and standardization process for healthcare providers, healthcare systems, and patients.

Cheryl Allen, BSPharm, MBA, Vice President of Industry Relations at Diplomat Pharmacy, discusses the rapidly changing oncology market and what to look for in the drug pipeline.

Robert F. Sidonio Jr, MD, assistant professor of pediatrics at Emory University, Children's Healthcare of Atlanta, gives an overview of the different hemophilia therapies and recent improvements in the treatment landscape.

Pharmacy Times’ Ed Cohen, PharmD, FAPha, interviews Miranda Rochol, Healthcare Product Management & Strategy Executive for IQVIA, about opportunities for pharmacy professionals utilizing the company’s services.

Tim Boonstra, RPh, Pharmacy Manager at Fairview Center for Bleeding and Clotting Disorders, discusses the collaborative approach taken at his clinic in the management and treatment of patients with hemophilia.

Cheryl Allen, BSPharm, MBA, Vice President of Industry Relations at Diplomat Pharmacy, discusses the increasing cost burden of cancer therapies and future strategies for mitigating costs.